NASDAQ:RETA Investor Alert: Lawsuit Alleges Securities Laws Violations by Reata Pharmaceuticals, Inc
January 27, 2022 at 13:00 PM EST
San Diego, CA -- (SBWIRE) -- 01/27/2022 -- An investor, who purchased shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA), filed a lawsuit over alleged violations of Federal Securities Laws by Reata Pharmaceuticals, Inc.
